medication choices for osteoporosis
Evista (raloxifene), approved by the FDA for the prevention and treatment of osteoporosis for women after menopause, belongs to a class of drugs called selective estrogen receptor modulators (SERMs). Evista has estrogen-like effects on the skeleton, but blocks estrogen effects in the breast and uterus.